\
&
Contact us
\
&
Contact us
Published on | 1 hour ago
ProgrammesEIT Health, a Knowledge and Innovation Community of the European Institute of Innovation and Technology (EIT), is inviting consortia of technology transfer offices and entrepreneurship support providers to deliver activities under the "Beyond the Lab: From Research to Venture" programme in 2027 and 2028.
This six-month venture-building programme helps researchers turn promising healthcare innovations into incorporated start-ups. The selected consortium will deliver live masterclasses, structured mentoring and a final Pitch Day for two cohorts, while EIT Health will oversee the programme design and management.
Applicants must form a consortium of two technology transfer offices representing higher education institutions or research organisations and one entrepreneurship support provider. The consortium should combine expertise in intellectual property and technology transfer with practical experience in venture building, market validation, business model development and investment readiness.
Funding of up to €77,000 is available in 2027 and 2028. Application deadline is 2 November 2026. You can find all the details here. An online Q&A session will take place on 15 October 2026 at 10:00 CET. Register here.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
